WebFounded in 2009, Flagship Biosciences, Inc., is a technology-driven spatial biology and biomarker services company delivering the most accurate and informative data available. WebAug 31, 2024 · Flagship Biosciences offers cutting-edge spatial biology services, powered by its patented AI image analysis technology that improves the accuracy of tissue-based …
Flagship Biosciences Mergers and Acquisitions Summary Mergr
WebAmpersand is a Massachusetts-based financial institution that provides investment services for industries including medical devices, pharma, and life sciences. Primary competitors include Altaris, Vivo Capital, WindRose and 16 more. ... Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences. WebJul 9, 2024 · Information on valuation, funding, cap tables, investors, and executives for Flagship Biosciences. Use the PitchBook Platform to explore the full profile. read across approach toxicology
Ampersand Biomedicines - Crunchbase Company Profile & Funding
WebFounded in 1988, Ampersand is a middle-market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. WebAug 31, 2024 · Flagship Biosciences offers cutting-edge spatial biology services, powered by its patented AI image analysis technology that improves the accuracy of tissue-based … WebSep 1, 2024 · BROOMFIELD — Flagship Biosciences Inc., a biotechnology company that uses artificial intelligence to analyze tissue samples, has acquired Interpace Pharma Solutions, a division of New Jersey-based Interpace Biosciences that specializes in cytogenetic, molecular pathology, and genomic profiling solutions. Terms of the deal … read across america t shirts